Last reviewed · How we verify

NCT03676452: Active@Home

The Effects of an Exergame Training on Body and Brain of Older Adults

Completed NA Last updated 19 April 2019
What this trial tests

NA trial testing Active@Home exergame training in Fall Prevention in Healthy Aging in 37 participants. Completed in 18 April 2019.

Timeline
1 July 2018
Primary endpoint
18 April 2019
18 April 2019

Quick facts

Lead sponsorEling DeBruin
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment37
Start date1 July 2018
Primary completion18 April 2019
Estimated completion18 April 2019
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Eling DeBruin

Who can join

65 and older, any sex, with Fall Prevention in Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effects of an exergame training including strength, balance, and cognitive training components on motor functions, cognition and brain structure of older adults. The primary objective is to determine the effects of the home-based multicomponent exergame training on motor and cognitive functions of older adults compared to a usual care waitlist control group. To understand the underlying mechanisms, the secondary objective is to assess the effect of the exergame training on neuronal level (brain structure). The study design is a randomized controlled trial including 40 healthy (self-reported), independently living older adults aged 65 years and older. The intervention period lasts for 16-18 weeks (no longer than two weeks of break/holiday allowed) with three training sessions per week each lasting about 40 minutes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of an In-home Multicomponent Exergame Training on Physical Functions, Cognition, and Brain Volume of Older Adults: A Randomized Controlled Trial.
    Adcock M, Fankhauser M, Post J, Lutz K, et al · · 2019 · cited 71× · PMID 32047751 · DOI 10.3389/fmed.2019.00321

Verify or expand the search:

Other Eling DeBruin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03676452.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing